Dr. Leis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5777 E. Mayo Boulevard
Phoenix, AZ 85050- Is this information wrong?
Summary
- Dr. Jose Leis is an oncologist in Scottsdale, AZ and is affiliated with Mayo Clinic Hospital. He received his medical degree from University of Arizona College of Medicine - Tucson and has been in practice 31 years. He specializes in hematologic oncology and is experienced in acute and chronic leukemias, lymphoma, myelodysplasia, myelofibrosis, and bone marrow transplantation.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1993
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1986 - 1989
University of Arizona College of MedicineClass of 1986
Certifications & Licensure
OR State Medical License 1997 - Present
AZ State Medical License 2007 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Press Ganey Top Provider Recognition Award Office of Mayo Clinic Experience, Mayo Clinic Arizona, 2020
- Top Doctors:Arizona State Castle Connolly, 2013-2020
- Top Faculty Award Mayo School of Continuous Professional Development, 2011-2012
- Join now to see all
Clinical Trials
- Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia Start of enrollment: 2005 Aug 01
- Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2008 Feb 01
- Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2009 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms.Charles Gaulin, Fiona Craig, Shannon Fortin Ensign, Ryan Robetorye, Sarah Gibson, Katalin Kelemen, Nandita Khera, Jose Leis, Mazie Tsang, Allison Rosenthal, Javier Mun...> ;Leukemia & Lymphoma. 2023 Dec 1
- 2 citationsResponse to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.Wiedmeier-Nutor, J., Iqbal, M., Rosenthal, A., Bezerra, E., Garcia-Robledo, J., Bansal, R., Johnston, P., Hathcock, M., Larsen, J., Bergsagel, P., Wang, Y., Reeder, C....> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Jun 1
- 2 citationsDTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, m...Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander, Allison C Rosenthal, Jose F Leis, Han W Tun, Muhamad Alhaj Moustafa, Madiha Iqba...> ;American Journal of Hematology. 2023 May 1
- Join now to see all
Journal Articles
- Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical CentreSameer A Parikh, Tait D Shanafelt, Paul J Hampel, Jose F Leis, Neil E Kay, Wei Ding, Timothy G Call, Deborah Bowen, Eli Muchtar, British Journal of Haematology
Abstracts/Posters
- Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E19...Jose F. Leis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphoc...Jose F. Leis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell LymphocytosisJose F. Leis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Management of Steroid Resistant Acute and Chronic GVHD: Are We Making Progress?CIBMTR and ASBMT BMT Tandem Meeting, Salt Lake City, UT - 2/2018
- CLL: What To Do After BTK Inhibitor Therapy FailsGreat Debates & Updates in Hematologic Malignancies, New York, NY - 4/2018
- How I Treat Newly Diagnosed, Relapsed, and Transformed CLL PatientsAmerican Society of Hematology (ASH) Meeting on Hematologic Malignancies, Chicago, IL - 9/2019
- Join now to see all
Professional Memberships
- Member
- Member
- American Society for Blood and Marrow TransplantationMember
- European Society of HematologyMember
Hospital Affiliations
Mayo Clinic HospitalPhoenix, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
